- Home
- TERN vs DGICA Comparison
TERN vs DGICA Comparison
Compare TERN & DGICA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TERN
- DGICA
- Stock Information
- Founded
- TERN 2017
- DGICA 1986
- Country
- TERN United States
- DGICA United States
- Employees
- TERN N/A
- DGICA N/A
- Industry
- TERN Biotechnology: Pharmaceutical Preparations
- DGICA Property-Casualty Insurers
- Sector
- TERN Health Care
- DGICA Finance
- Exchange
- TERN Nasdaq
- DGICA Nasdaq
- Market Cap
- TERN 713.2M
- DGICA 705.0M
- IPO Year
- TERN 2021
- DGICA N/A
- Fundamental
- Price
- TERN $8.39
- DGICA $19.16
- Analyst Decision
- TERN Buy
- DGICA Hold
- Analyst Count
- TERN 7
- DGICA 1
- Target Price
- TERN $14.99
- DGICA $18.00
- AVG Volume (30 Days)
- TERN 1.1M
- DGICA 122.7K
- Earning Date
- TERN 11-11-2025
- DGICA 10-30-2025
- Dividend Yield
- TERN N/A
- DGICA 3.81%
- EPS Growth
- TERN N/A
- DGICA 965.80
- EPS
- TERN N/A
- DGICA 2.34
- Revenue
- TERN N/A
- DGICA $993,644,532.00
- Revenue This Year
- TERN N/A
- DGICA $2.26
- Revenue Next Year
- TERN N/A
- DGICA $3.46
- P/E Ratio
- TERN N/A
- DGICA $8.18
- Revenue Growth
- TERN N/A
- DGICA 3.36
- 52 Week Low
- TERN $1.87
- DGICA $14.17
- 52 Week High
- TERN $9.03
- DGICA $21.12
- Technical
- Relative Strength Index (RSI)
- TERN 58.46
- DGICA 52.45
- Support Level
- TERN $7.91
- DGICA $18.67
- Resistance Level
- TERN $9.03
- DGICA $19.76
- Average True Range (ATR)
- TERN 0.42
- DGICA 0.42
- MACD
- TERN -0.01
- DGICA -0.05
- Stochastic Oscillator
- TERN 59.43
- DGICA 53.47
About TERN Terns Pharmaceuticals Inc.
Terns Pharmaceuticals Inc is a clinical-stage biopharmaceutical company. The company is developing a portfolio of small-molecule single-agent and combination therapy candidates for the treatment of non-alcoholic steatohepatitis, NASH, and other chronic liver diseases. Its product candidates include TERN-701, TERN-601, TERN-501 and TERN-800.
About DGICA Donegal Group Inc.
Donegal Group Inc is an insurance holding company that offers businesses and individuals personal and commercial lines of property and casualty insurance. The company's reportable segments are its Investment function, Personal lines of insurance, and Commercial lines of insurance. Personal lines products consist mainly of homeowners and private passenger automobile policies. The Commercial lines products of its insurance subsidiaries consist mainly of commercial automobile, commercial multi-peril, and workers' compensation policies. The group mainly operates in the United States.